Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
about
E2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitrop38α MAPK is required for arsenic-induced cell transformationPotential role of sodium-proton exchangers in the low concentration arsenic trioxide-increased intracellular pH and cell proliferationNovel interactions between FOXM1 and CDC25A regulate the cell cycle.Metals and breast cancer: risk factors or healing agents?Arsenic toxicology: translating between experimental models and human pathology.PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.Systematic dissection of dysregulated transcription factor-miRNA feed-forward loops across tumor types.AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivoThe evolving use of arsenic in pharmacotherapy of malignant disease.Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.Opposing roles of ICAT and Wnt/β-catenin signaling in NSC67657-induced monocytic differentiation.p38 and extracellular signal-regulated kinases activations have opposite effects on primary-cultured rat cerebellar granule neurons exposed to sodium arsenite.Neuroglobin involvement in the course of arsenic toxicity in rat cerebellar granule neurons.Toxic elements as biomarkers for breast cancer: a meta-analysis study.
P2860
Q28393378-09CC210F-09AE-48CD-AE1F-27AFADC41758Q28393791-F10AE463-DD9C-4D93-B7A6-FA6C6658D373Q28485512-88FA5FAA-03AE-4277-B90D-A9B8F43097F2Q34512283-C809796F-A869-4FB4-94E7-78028E78FFE1Q35127590-8CEA873B-1154-48A6-8BAD-6D9017E6A13CQ35591935-67A0ADD2-6D8C-494D-AA5F-418D2E999CEFQ35958274-19F13D0F-406F-49E8-8C9F-2FBC301364E3Q37096690-8860E83D-30F4-4121-9C29-A6873F1CD126Q37480571-2A743480-752B-442D-B57B-71FDA3D3C7A8Q37702233-85AB330C-E3B4-4301-A89B-F3FB098DC518Q38089629-63D8D991-6996-40B8-9237-FA308E31BC9DQ38825290-3616223C-2E00-4572-8A48-41D9196FC637Q38904895-D86075D0-0AE4-4C5A-8954-52CE2E65749CQ39223163-9A333FDC-7312-4B8D-B5EB-EF782D667ED1Q42378393-CD071FB1-C24E-4B85-952A-77B2B93D2E5FQ42707838-193699B4-AAA8-4AC2-9550-493DB1A22BA9Q44006484-CAE0D11F-71DF-4C0B-854E-40AC5C8271ECQ47549876-0A3560D1-26D5-455C-B7F1-C8BA26360213
P2860
Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Activation of the p38 MAPK/Akt ...... te-induced cell proliferation.
@en
Activation of the p38 MAPK/Akt ...... te-induced cell proliferation.
@nl
type
label
Activation of the p38 MAPK/Akt ...... te-induced cell proliferation.
@en
Activation of the p38 MAPK/Akt ...... te-induced cell proliferation.
@nl
prefLabel
Activation of the p38 MAPK/Akt ...... te-induced cell proliferation.
@en
Activation of the p38 MAPK/Akt ...... te-induced cell proliferation.
@nl
P2093
P2860
P356
P1476
Activation of the p38 MAPK/Akt ...... ite-induced cell proliferation
@en
P2093
Allison J Cox
Bruce H Davis
Con Sullivan
Geying Fang
Kathleen T Davis
Youhong Liu
P2860
P304
P356
10.1002/JCB.22886
P577
2010-12-01T00:00:00Z